ABSTRACT
Glucocorticoids, proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), certain antiepileptic drugs, and aromatase inhibitors have significant adverse effects on bone. Healthcare providers should monitor the bone health of patients on these agents, supplement their intake of calcium and vitamin D, encourage weight-bearing exercise, and initiate osteoporosis-prevention treatment as indicated.
Footnotes
Dr. Bolster has disclosed performing a clinical research study for Eli Lilly and owning stock or stock options in Johnson & Johnson.
- Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.
- Faye N. Hant, DO, MSCR⇑
- Associate Professor of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC
- ADDRESS:
Faye N. Hant, DO, MSCR, Associate Professor of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 816, Charleston, SC 29425; hant{at}musc.edu
- Marcy B. Bolster, MD
ABSTRACT
Glucocorticoids, proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), certain antiepileptic drugs, and aromatase inhibitors have significant adverse effects on bone. Healthcare providers should monitor the bone health of patients on these agents, supplement their intake of calcium and vitamin D, encourage weight-bearing exercise, and initiate osteoporosis-prevention treatment as indicated.
Footnotes
Dr. Bolster has disclosed performing a clinical research study for Eli Lilly and owning stock or stock options in Johnson & Johnson.
- Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- No citing articles found.